HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $151,000 | -79.6% | 14,081 | -69.2% | 0.00% | -100.0% |
| Q1 2021 | $742,000 | +267.3% | 45,788 | +378.8% | 0.00% | – |
| Q4 2020 | $202,000 | +17.4% | 9,564 | -18.1% | 0.00% | – |
| Q2 2020 | $172,000 | +35.4% | 11,684 | +8.3% | 0.00% | – |
| Q1 2020 | $127,000 | -52.4% | 10,791 | -5.2% | 0.00% | – |
| Q4 2019 | $267,000 | -2.9% | 11,382 | -23.3% | 0.00% | – |
| Q3 2019 | $275,000 | -52.7% | 14,842 | -52.6% | 0.00% | -100.0% |
| Q2 2019 | $582,000 | -4.1% | 31,303 | +25.9% | 0.00% | 0.0% |
| Q1 2019 | $607,000 | -0.8% | 24,855 | +5.3% | 0.00% | 0.0% |
| Q4 2018 | $612,000 | -26.0% | 23,605 | -9.7% | 0.00% | 0.0% |
| Q3 2018 | $827,000 | -26.9% | 26,127 | -10.2% | 0.00% | -50.0% |
| Q2 2018 | $1,131,000 | +41.6% | 29,109 | +0.6% | 0.00% | +100.0% |
| Q1 2018 | $799,000 | – | 28,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |